cis-1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride
| Code | Size | Price |
|---|
| TAR-T77505-500mg | 500mg | £111.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C
Documents
Further Information
Bioactivity:
cis-1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride is an antimicrobial agent used in cosmetics as a cosmetic preservative and antistatic agent.cis-1-(3-Chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride is an oral teratogen, but not a dermal teratogen, and has been dosed in rats at doses exceeding the expected cumulative exposures for cosmetics.
CAS:
51229-78-8
Molecular Weight:
251.16
Purity:
0.98
SMILES:
C(/C=C\Cl)[N+]12CN3CN(C1)CN(C2)C3.[Cl-]
References
Silverberg JI, et al. Prevalence and trend of allergen sensitization in patients with a diagnosis of stasis dermatitis referred for patch testing, North American contact dermatitis group data, 2001-2016. Arch Dermatol Res. 2022;314(9):857-867.
Multisanti C R, et al. Short-term in vitro exposure of Pinctada imbricata?s haemocytes to quaternium-15: Exploring physiological and cellular responses. Environmental Toxicology and Pharmacology. 2023; 101: 104198.